These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35220635)

  • 1. A systematic review of oral retinoids for treatment of acneiform eruptions induced by epidermal growth factor receptor inhibitors.
    Bierbrier R; Lam M; Pehr K
    Dermatol Ther; 2022 May; 35(5):e15412. PubMed ID: 35220635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acneiform eruptions with combination targeted cancer therapy in colorectal cancer patients.
    Ibraheim MK; Lo J; Gupta R; Parseghian C; Patel AB
    Support Care Cancer; 2022 Oct; 30(10):8051-8058. PubMed ID: 35771289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Analysis of Risk Factors for the Development of Acneiform Eruptions in Patients on Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors.
    Bierbrier R; D'Aguanno K; Oliel S; Zeng Y; Esfahani K; Pehr K
    J Cutan Med Surg; 2023 Nov; 27(6):614-620. PubMed ID: 37942582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta-analysis.
    Gorji M; Joseph J; Pavlakis N; Smith SD
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):526-539. PubMed ID: 35352492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective chart review on oral retinoids as a treatment for epidermal growth factor receptor inhibitor- and mitogen-activated protein kinase kinase inhibitor-induced acneiform eruptions.
    Andrews ED; Garg N; Patel AB
    J Am Acad Dermatol; 2020 Apr; 82(4):998-1000. PubMed ID: 31604105
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe EGFR inhibitor-induced acneiform eruption responding to dapsone.
    Beshay A; Petersen M; Rhoads JLW
    Dermatol Online J; 2021 Jul; 27(7):. PubMed ID: 34391331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of epidermal growth factor receptor inhibitor-induced acneiform eruption with topical recombinant human epidermal growth factor.
    Shin JU; Park JH; Cho BC; Lee JH
    Dermatology; 2012; 225(2):135-40. PubMed ID: 23006507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin.
    Requena C; Llombart B; Sanmartín O
    Cutis; 2012 Aug; 90(2):77-80. PubMed ID: 22988651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reader Comment Regarding "Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors".
    Fournier C; Sauder MB
    J Cutan Med Surg; 2023; 27(3):294. PubMed ID: 36927192
    [No Abstract]   [Full Text] [Related]  

  • 10. Survey of Oncologists and Dermatologists in Canada on the Management of Acneiform Eruptions Induced by Epidermal Growth Factor Receptor Inhibitors.
    Bierbrier R; Esfahani K; Pehr K
    J Cutan Med Surg; 2022; 26(6):624-625. PubMed ID: 35980317
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe acneiform skin reaction during therapy with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor.
    Eames T; Landthaler M; Karrer S
    Eur J Dermatol; 2007; 17(6):552-3. PubMed ID: 17951151
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased infection rates associated with tetracycline therapy given for epidermal growth factor receptor inhibitor (EGFRI)-associated acneiform eruption: A retrospective study of data from two cancer centers.
    Magnino MZ; Perry DJ; Subramaniam DS; DeKlotz CMC
    J Am Acad Dermatol; 2020 Feb; 82(2):486-488. PubMed ID: 31279812
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of topical benzoyl peroxide for prolonged acneiform eruptions induced by cetuximab and panitumumab: A multicenter, phase II trial.
    Tsutsui K; Kikuchi K; Nozawa K; Takashima A; Tsuchiyama K; Namikawa K; Aiba S; Yamazaki N
    J Dermatol; 2021 Jul; 48(7):1077-1080. PubMed ID: 33682955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.
    Katzer K; Tietze J; Klein E; Heinemann V; Ruzicka T; Wollenberg A
    Eur J Dermatol; 2010; 20(1):82-4. PubMed ID: 19797039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of treatment for acneiform eruptions related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC): A protocol of systematic review and network meta-analysis.
    He C; Lin R; Zhang J; Sun L; Lin J; Lin L
    Medicine (Baltimore); 2021 Jan; 100(1):e23875. PubMed ID: 33429746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erlotinib-induced pustular eruption.
    Cusano F; Ferrara G; Barletta E; Ingordo V
    G Ital Dermatol Venereol; 2009 Feb; 144(1):93-6. PubMed ID: 19218915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption.
    Kikuchi K; Nozawa K; Yamazaki N; Nakai Y; Higashiyama A; Asano M; Fujiwara Y; Kanda S; Ohe Y; Takashima A; Boku N; Inoue A; Takahashi M; Mori T; Taguchi O; Inoue Y; Mizutani H
    J Dermatol; 2019 Jan; 46(1):18-25. PubMed ID: 30402978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing between isotretinoin and acitretin for epidermal growth factor receptor inhibitor and small molecule tyrosine kinase inhibitor acneiform eruptions.
    Costello CM; Hill HE; Brumfiel CM; Yang YW; Swanson DL
    J Am Acad Dermatol; 2021 Mar; 84(3):840-841. PubMed ID: 33039483
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].
    Wollenberg A; Moosmann N; Kroth J; Heinemann V; Klein E
    Hautarzt; 2007 Jul; 58(7):615-8. PubMed ID: 17146641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR inhibitors: clinical aspects, risk factors and biomarkers for acneiform eruptions and other mucosal and cutaneous adverse effects.
    Recuero JK; Fitz JR; Pereira AA; Bonamigo RR
    An Bras Dermatol; 2023; 98(4):429-439. PubMed ID: 36990917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.